[{"orgOrder":0,"company":"ZZ Biotech","sponsor":"National Institute of Neurological Disorders and Stroke | University of Southern California | University of Cincinnati | University of South Carolina","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"U.S.A","productType":"Protein","year":"2022","type":"Inapplicable","leadProduct":"3K3A-APC","moa":"PAR-1\/protein C","graph1":"Cardiology\/Vascular Diseases","graph2":"Phase III","graph3":"ZZ Biotech","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Infusion","sponsorNew":"ZZ Biotech \/ National Institute of Neurological Disorders and Stroke | University of Southern California | University of Cincinnati | University of South Carolina","highestDevelopmentStatusID":"10","companyTruncated":"ZZ Biotech \/ National Institute of Neurological Disorders and Stroke | University of Southern California | University of Cincinnati | University of South Carolina"},{"orgOrder":0,"company":"ZZ Biotech","sponsor":"National Institute of Neurological Disorders and Stroke | Cedars-Sinai | Massachusetts General Hospital | University of Iowa","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"U.S.A","productType":"Protein","year":"2014","type":"Inapplicable","leadProduct":"3K3A-APC","moa":"PAR-1\/protein C","graph1":"Cardiology\/Vascular Diseases","graph2":"Phase III","graph3":"ZZ Biotech","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Infusion","sponsorNew":"ZZ Biotech \/ National Institute of Neurological Disorders and Stroke | Cedars-Sinai | Massachusetts General Hospital | University of Iowa","highestDevelopmentStatusID":"10","companyTruncated":"ZZ Biotech \/ National Institute of Neurological Disorders and Stroke | Cedars-Sinai | Massachusetts General Hospital | University of Iowa"},{"orgOrder":0,"company":"ZZ Biotech","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"U.S.A","productType":"Protein","year":"2020","type":"Inapplicable","leadProduct":"3K3A-APC","moa":"PAR-1\/protein C","graph1":"Cardiology\/Vascular Diseases","graph2":"Phase III","graph3":"ZZ Biotech","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Infusion","sponsorNew":"ZZ Biotech \/ Undisclosed","highestDevelopmentStatusID":"10","companyTruncated":"ZZ Biotech \/ Undisclosed"},{"orgOrder":0,"company":"ZZ Biotech","sponsor":"National Institute of Neurological Disorders and Stroke","pharmaFlowCategory":"D","therapeuticArea":"Cardiology\/Vascular Diseases","country":"U.S.A","productType":"Protein","year":"2022","type":"Funding","leadProduct":"3K3A-APC","moa":"PAR-1\/protein C","graph1":"Cardiology\/Vascular Diseases","graph2":"Phase III","graph3":"ZZ Biotech","amount2":0.029999999999999999,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0.029999999999999999,"dosageForm":"Infusion","sponsorNew":"ZZ Biotech \/ National Institute of Neurological Disorders and Stroke","highestDevelopmentStatusID":"10","companyTruncated":"ZZ Biotech \/ National Institute of Neurological Disorders and Stroke"},{"orgOrder":0,"company":"ZZ Biotech","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Protein","year":"2012","type":"Inapplicable","leadProduct":"3K3A-APC","moa":"PAR-1\/protein C","graph1":"Undisclosed","graph2":"Phase I","graph3":"ZZ Biotech","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"ZZ Biotech \/ Undisclosed","highestDevelopmentStatusID":"6","companyTruncated":"ZZ Biotech \/ Undisclosed"},{"orgOrder":0,"company":"ZZ Biotech","sponsor":"ZZ Biotech","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"AUSTRALIA","productType":"Protein","year":"2021","type":"Inapplicable","leadProduct":"3K3A-APC","moa":"PAR-1\/protein C","graph1":"Neurology","graph2":"Phase II","graph3":"ZZ Biotech","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"ZZ Biotech \/ ZZ Biotech","highestDevelopmentStatusID":"8","companyTruncated":"ZZ Biotech \/ ZZ Biotech"}]